logo
Sign in

SBTX Stock Price, Chart, Stats & News

SkinBioTherapeutics Plc
Save

SkinBioTherapeutics Plc (SBTX) does not currently pay a dividend.

24.62M
Market cap
Current P/E
Forward P/E

SBTX chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

SkinBioTherapeutics Plc is a life sciences enterprise dedicated to enhancing human health through the exploration and development of technologies that harness the power of the human microbiome. The company has developed two primary technological platforms: SkinBiotix: This innovative solution is designed to strengthen the skin's natural barrier, offer protection against infections, and promote the repair of damaged skin. AxisBiotix: Focusing on the intricate link between gut health and skin conditions, this technology aims to mitigate the symptoms experienced by individuals with psoriasis.

Similar securities

Based on sector and market capitalization

Report issue